Abstract
BackgroundAchieving clinical remission and low disease activity (LDA) in early rheumatoid arthritis (RA) limits joint damage and disability.1 Biologics such as anti-TNF agents have been shown to rapidly induce remission...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
